RemAb Therapeutics attends the 15th Annual Anglonordic Life Science Conference

RemAb Therapeutics attended the 15th Annual Anglonordic Life Science Conference in London last May. The main aim of RemAb Therapeutics was to introduce the company to European investors and R&D companies from the Nordics and the UK.

 

More information